A detailed history of British Columbia Investment Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, British Columbia Investment Management Corp holds 339,155 shares of ABBV stock, worth $57.8 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
339,155
Previous 211,517 60.34%
Holding current value
$57.8 Million
Previous $38.5 Million 51.03%
% of portfolio
0.36%
Previous 0.27%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $19.8 Million - $23.1 Million
127,638 Added 60.34%
339,155 $58.2 Million
Q1 2024

May 14, 2024

BUY
$159.82 - $182.1 $1.33 Million - $1.52 Million
8,340 Added 4.1%
211,517 $38.5 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $5.87 Million - $6.61 Million
42,636 Added 26.56%
203,177 $31.5 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $151,491 - $175,373
1,134 Added 0.71%
160,541 $23.9 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $168,420 - $209,587
1,271 Added 0.8%
159,407 $21.5 Million
Q1 2023

May 12, 2023

BUY
$144.61 - $166.54 $178,014 - $205,010
1,231 Added 0.78%
158,136 $25.2 Million
Q4 2022

Feb 10, 2023

SELL
$138.31 - $165.87 $2.52 Million - $3.02 Million
-18,205 Reduced 10.4%
156,905 $25.4 Million
Q3 2022

Nov 10, 2022

SELL
$134.21 - $153.93 $4.08 Million - $4.68 Million
-30,383 Reduced 14.79%
175,110 $23.5 Million
Q2 2022

Aug 12, 2022

SELL
$137.62 - $174.96 $9.34 Million - $11.9 Million
-67,866 Reduced 24.83%
205,493 $31.5 Million
Q1 2022

May 12, 2022

SELL
$131.98 - $163.75 $4.94 Million - $6.13 Million
-37,413 Reduced 12.04%
273,359 $44.3 Million
Q4 2021

Feb 11, 2022

SELL
$107.43 - $135.93 $1.7 Million - $2.15 Million
-15,845 Reduced 4.85%
310,772 $42.1 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $27,451 - $31,161
-258 Reduced 0.08%
326,617 $35.2 Million
Q2 2021

Aug 09, 2021

BUY
$105.21 - $117.21 $3.89 Million - $4.33 Million
36,981 Added 12.76%
326,875 $36.8 Million
Q1 2021

Apr 30, 2021

SELL
$102.3 - $112.62 $912,822 - $1 Million
-8,923 Reduced 2.99%
289,894 $31.4 Million
Q4 2020

Feb 02, 2021

SELL
$80.49 - $108.67 $641,263 - $865,773
-7,967 Reduced 2.6%
298,817 $32 Million
Q3 2020

Nov 10, 2020

BUY
$85.91 - $100.83 $2.02 Million - $2.38 Million
23,566 Added 8.32%
306,784 $26.9 Million
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $8.9 Million - $11.9 Million
121,312 Added 74.93%
283,218 $27.8 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $12.1 Million - $18.3 Million
-186,978 Reduced 53.59%
161,906 $12.3 Million
Q4 2019

Feb 12, 2020

SELL
$72.13 - $90.25 $10.9 Million - $13.6 Million
-150,889 Reduced 30.19%
348,884 $30.9 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $3.03 Million - $3.64 Million
-48,062 Reduced 8.77%
499,773 $37.8 Million
Q2 2019

Aug 12, 2019

BUY
$65.7 - $83.98 $5.12 Million - $6.54 Million
77,919 Added 16.58%
547,835 $39.8 Million
Q1 2019

May 08, 2019

SELL
$77.14 - $90.79 $9.69 Million - $11.4 Million
-125,630 Reduced 21.09%
469,916 $37.9 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $1.6 Million - $1.98 Million
20,596 Added 3.58%
595,546 $54.9 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $16.9 Million - $18.7 Million
-189,598 Reduced 24.8%
574,950 $54.4 Million
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $7.99 Million - $9.46 Million
89,019 Added 13.18%
764,548 $70.8 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $1.87 Million - $2.5 Million
-20,274 Reduced 2.91%
675,529 $63.9 Million
Q4 2017

Feb 20, 2018

BUY
$89.56 - $98.21 $3.95 Million - $4.33 Million
44,130 Added 6.77%
695,803 $67.3 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $45.5 Million - $58.1 Million
651,673
651,673 $57.9 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track British Columbia Investment Management Corp Portfolio

Follow British Columbia Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of British Columbia Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on British Columbia Investment Management Corp with notifications on news.